Abstract
The recent progress in tumor immunology exemplifies the successful application of modern biotechnology for the understanding of the complex natural or therapy-induced phenomenon of immune-mediated rejection of cancer. Tumor antigens recognized by T cells were identified and successfully utilized in active immunization trials for the induction of tumor-antigen specific T cells. This achievement has left, however, the clinicians and researchers perplexed by the paradoxical observation of the immunization-induced T cells can recognize tumor cells in standard assays but most often cannot induce tumor regression. In this presentation, we will argue that successful immunization is one of several steps required for tumor clearance but more work needs to be done to understand how T cells can localize and be effective at the receiving end within a tumor microenvironment in most cases not conducive to the execution of their effector function. In fact, metastatic melanoma stands out among human cancers because of its immune responsiveness. Yet, the reason(s) remain(s) unclear. We believe that the key to the understanding of this complex phenomenon relies on the real-time study of tumor/host interactions in the tumor microenvironment. Most likely, T cells induced by immunization can reach the tumor site but they are not capable of performing their effector function because they encounter a tumor microenvironment not conducive to T cell activation. In this chapter, we will review some of the basic approaches that may help solve this puzzle by studying directly human disease and its adaptation to treatment.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Qin, Z., and Blankenstein, T., 2004, A cancer immunosurveillance controversy. Nat Immunol, 5:3–4.
Schreiber, R.D., Old, L.J., Hayday, A.C., and Smyth, M.J., 2004, Response to ‘A cancer immunosurveillance controversy'. Nat Immunol, 5:4–5.
Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., and Schreiber, R.D., 2002, Cancer immunoediting: from immunosurveillance to tumour escape. Nat Immunol, 3:991–8.
Boon, T., van Baren, N., 2003, Immunosurveillance against cancer and immunotherapy—synergy or antagonism?. N Engl J Med, 348:252–4.
Naito Y., Saito K., Shiiba K., Ohuchi A., Saigenji K., Nagura H., and Ohtani H., 1998, CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res, 58:3491–3494.
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P.A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., 2003, Liebman, M. N., Rubin, S.C., and Coukos, G., Intratumoural T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med, 348:203–213.
Mihm, M., Clemente, C., and Cascinelli, N., 1996, Tumour infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Investig, 74:43–47.
Schumacher, K., Haensch, W., Roefzaad, C., and Schlag, P.M., 2001, Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res, 61:3932–3936.
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T., 1991, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254:1643–1647.
Boon, T., and van der Bruggen, P., 1996, Human tumour antigens recognized by T lymphocytes. J Exp Med, 183:725–729.
Renkvist, N., Castelli, C., Robbins P. F., and Parmiani, G., 2001, A listing of human tumour antigens recognized by T cells. Cancer Immunol Immunother, 50:3–15.
Jager, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager D., Oesch, F., and Knuth, A., 1997, Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer, 71:142–147.
Ferrone, S., and Marincola, F.M., 1995, Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today, 16:487–494.
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Perez-Villar, J.J., Lopez-Botet, M., Duggan-Keen, M., and Stern, P.L., 1997, Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today, 18:89–95.
Hicklin, D.J., Marincola, F.M., and Ferrone, S., 1999, HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today, 5:178–186.
Marincola, F.M., Jaffee, E.M., Hicklin, D.J., and Ferrone, S., 2000, Escape of human solid tumours from T cell recognition: molecular mechanisms and functional significance. Adv Immunol, 74:181–273.
Lee, K.H., Panelli, M.C., Kim, C.J., Riker, A.I., Bettinotti, M.P., Roden, M.M., Fetsch, P., Abati, A., Rosenberg, S.A., and Marincola, F.M., 1998, Functional dissociation between local and systemic immune response following peptide vaccination. J Immunol, 161:4183–4194.
Kammula, U.S., Lee, K.H., Riker, A.I., Wang, E., Ohnmacht, G.A., Rosenberg, S.A., and Marincola, F.M., 1999, Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumour specimens. J Immunol, 163:6867–6879.
Panelli, M.C., Riker, A., Kammula, U., Wang, E., Lee, K.H., Rosenberg, S.A., and Marincola, F.M., 2000, Expansion of tumour/T cell pairs from fine needle aspirates (FNA) of melanoma metastases. J Immunol, 164:495–504.
Pellegrini P., Berghella A.M., Del Beato T., Cicia S., Adorno D., and Casciani, C.U., 1996, Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother, 42:1–8.
Yoong, K.F., and Adams, D.H., 1998, Interleukin 2 restores CD3-ζ chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases. Br J Cancer, 77:1072–1081.
Lee, P.P., Yee, C., Savage, P.A., Fong, L., Brockstedt, D., Weber, J.S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P.D., Roederer, M., and Davis, M.M., 1999, Characterization of circulating T cells specific for tumour-associated antigens in melanoma patients. Nat Med, 5:677–685.
Pasche, B., 2001, Role of transforming growth factor in cancer. J Cell Physiol. 186:153.
Khong, H.T., and Restifo, N.P., 2002, Natural selection of tumour variants in the generation of ‘tumour escape’ phenotypes. Nat Immunol, 3:999–1005.
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., Dalton, W., Jove, R., Pardoll, D., and Yu, H., 2004, Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumour cells. Nat Med, 10:48–54. Correction in: Nat Med, 10:209.
Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F.M., and Anichini, A., 2002, Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going?. J Natl Cancer Inst, 94:805–18.
Nagorsen, D., Scheibenbogen, C., Marincola, F.M., Letsch, A., and Keilholz, U., Natural T cell immunity against cancer. Clin Cancer Res, 9:4296–4303.
Nagorsen, D., Keilholz, U., Rivoltini, L., Schmittel, A., Letsch, A., Asemissen, A. M., Berger, G., Buhr, H. J., Thiel, E., and Scheibenbogen, C., 2000, Natural T cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res, 60:4850–4854.
Hamann, D., Baars, P. A., Rep, M.H.G., Hooibrink, B., Kerkhof-Garde, S.R., Klein, M.R., and van Lier, R.A.W., 1997, Phenotypical and functional separation of memory and effector human CD8+ T cells. J Exp Med, 186:1407–1418.
Scheibenbogen, C., Letsch, A., Schmittel, A., Asemissen, A.M., Thiel, E., and Keilholz, U., 2003, Rational peptide-based tumour vaccine development and T cell monitoring. Semin Cancer Biol, 13(6):423–429.
thor Straten, P., Becker, J.C., Guldberg, P., and Zeuthen, J., 1999, In situ T cells in melanoma. Cancer Immunol Immunother, 48(7):386–95.
Nagorsen, D., Fetsch, P.A., Abati, A., Marincola, F.M., and Panelli, M.C., 2004, Degree of CD14 expression in melanoma infiltrating mononuclear phagocytes, submitted.
Ropponen, K.M., Eskelinen, M.J., Lipponen, P.K., Alhava, E., and Kosma, V.M., 1997, Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol, 182:318–24.
Oberg, A., Samii, S., Stenling, R., and Lindmark, G., 2002, Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis, 17:25–9.
Funada, Y., Noguchi, T., Kikuchi, R., Takeno, S., Uchida, Y., and Gabbert, H.E., 2003, Prognostic significance of CD8+ T cell and macrophage peritumoural infiltration in colorectal cancer. Oncol Rep, 10:309–13.
Diederichsen, AC, Hjelmborg, JB, Christensen, PB, Zeuthen, J, and Fenger, C., 2003, Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother, 52:423–8.
Romero, P., Dunbar, P.R., Valmori, D., Pittet, M., Ogg, G.S., Rimoldi, D., Chen, J.L., Lienard, D., Cerottini, J.C., and Cerundolo, V., 1998, Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumour-specific cytolytic T lymphocytes. J Exp Med, 188:1641–1650.
Pittet, M.J., Valmori, D., Dunbar, P.R., Speiser, D.E., Lienard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.C., and Romero, P., 1999, High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med, 190:705–715.
Skinner, P.J., Daniels, M.A., Schmidt, C.S., Jameson, S.C., and Haase, A.T., 2000, Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol, 165:613–7.
Monsurro, V., Nagorsen, D., Wang, E., Provenzano, M., Dudley, M.E., Rosenberg, S.A., and Marincola, F.M., 2002, Functional heterogeneity of vaccine-induced CD8(+) T cells. J Immunol, 168:5933–42.
Gorski, J., Yassai, M., Zhu, X., Kissela, B., Kissella, B., corrected to Kissela, B., Keever, C., and Flomenberg, N., 1994, Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol, 152:5109–19.
Pannetier, C., Even, J., and Kourilsky, P., 1995, T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today, 16:176–81.
Willhauck, M., Scheibenbogen, C., Moehler, T., Pawlita, M., Thiel, E., and Keilholz, U., 2003, Restricted T cell repertoire in melanoma metastases regressing after cytokine therapy. Cancer Research, 63, 3483–5
Cranmer, L.D., Trevor, K.T., and Hersh, E.M., 2004, Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother, 53:275–306.
Dudley, M.E., and Rosenberg, S.A., 2003, Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer, 3:666–75.
Marincola, F.M., Wang, E., Herlyn, M., Seliger, B., and Ferrone, S., 2003, Tumours as elusive targets of T-cell-based active immunotherapy. Trends Immunol, 24:335–42.
Pockaj, B.A., Sherry, R.M., Wei, J.P., Yannelli, J.R., Carter, C.S., Leitman, S.F., Carasquillo, J.A., Steinberg, S.M., Rosenberg, S.A., and Yang, J.C., 1994, Localization of 111indium-labeled tumour infiltrating lymphocytes to tumour in patients receiving adoptive immunotherapy. augmentation with cyclophosphamide and correlation with response. Cancer, 73:1731–1737.
Matzinger, P., 1994, Tolerance, danger, and the extended family. Annu Rev Immunol, 12:991–1045.
Fuchs, E.J., and Matzinger, P., 1996, Is cancer dangerous to the immune system?. Semin Immunol, 8:271–280.
Ochsenbein, A.F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H., and Zinkernagel, R.M., 1999, Immune surveillance against a solid tumour fails because of immunological ignorance. Proc Natl Acad Sci USA, 96:2233–2238.
Gervois, N., Guilloux, Y., Diez, E., and Jotereau, F., 1996, Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumour peptide interactions. J. Exp. Med, 183:2403–2407.
Valitutti, S., Muller, S., Dessing, M., and Lanzavecchia, A., 1996, Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med, 183:1917–1921.
Scheibenbogen, C., Schadendorf, D., Bechrakis, N.E., Nagorsen, D., Hofmann, U., Servetopoulou, F., Letsch, A., Philipp, A., Foerster, M.H., Schmittel, A., Thiel, E., and Keilholz, U., 2003, Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides. Int J Cancer, 104:188–94.
Somasundaram, R., Jacob, L., Swoboda, R., Caputo, L., Song, H., Basak, S., Monos, D., Peritt, D., Marincola, F., Cai, D., Birebent, B., Bloome, E., Kim, J., Berencsi, K., Mastrangelo, M., and Herlyn, D., 2002, Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res, 62:5267–72.
Wolf, A.M., Wolf, D., Steurer, M., Gastl, G., Gunsilius, E., and Grubeck-Loebenstein, B., 2003, Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res, 9(2):606–12.
Sallusto, F., Lenig, D., Forster, R., Lipp, M., and Lanzavecchia, A., 1999, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature, 401:708–12.
Letsch, A., Keilholz, U., Assfalg, G., Mailander, V., Thiel, E., and Scheibenbogen, C., 2003, Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells. Cancer Res, 63:5582–6.
Letsch, A., Keilholz, U., Schadendorf, D., Assfalg, G., Asemissen, A.M., Thiel, E., and Scheibenbogen, C., 2004, Functional CCR9 Expression is Associated with Small Intestinal Metastasis. J Invest Dermatol, in press, 2004.
Hu, J.Y., Li, G.C., Wang, W.M., Zhu, J.G., Li, Y.F., Zhou, G.H., and Sun, Q.B., 2002, Transfection of colorectal cancer cells with chemokine MCP-3 (monocyte chemotactic protein-3) gene retards tumour growth and inhibits tumour metastasis. World J Gastroenterol 8:1067–72.
Crittenden, M., Gough, M., Harrington, K., Olivier, K., Thompson, J., and Vile, R.G., 2003, Expression of inflammatory chemokines combined with local tumour destruction enhances tumour regression and long-term immunity. Cancer Res, 63(17):5505–12.
Coukos, G., 2003, Immunohistochemistry of Tumours for Immune cells. Plenary Session Abstracts, SBT workshop on Cancer Biometrics, Bethesda.
Signore, A., Capriotti, G., Scopinaro, F., Bonanno, E., and Modesti, A., 2003, Radiolabelled lymphokines and growth factors for in vivo imaging of inflammation, infection and cancer. Trends Immunol, 24:395–402.
Lollini, P.L., and Forni, G., 2003, Cancer immunoprevention: tracking down persistent tumour antigens. Trends Immunol, 24:62–66.
Riker, A., Cormier, J., Panelli, M., Kammula, U., Wang, E., Abati, A., Fetsch, P., Lee, K.H., Steinberg, S., Rosenberg, S., and Marincola, F., 1999, Immune selection following antigen specific immunotherapy of melanoma. Surgery, 126:112–120.
Nielsen, M.B., and Marincola, F.M., 2000, Melanoma vaccines: the paradox of T cell activation without clinical response. Cancer Chemother Pharmacol, 46Suppl:S62–6.
Cormier, J.N., Hijazi, Y.M., Abati, A., Fetsch, P., Bettinotti, M., Steinberg, S.M., Rosenberg, S.A., and Marincola, F.M., 1998, Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer, 75:517–524.
Wang, E., and Marincola, F.M., 2000, A natural history of melanoma: serial gene expression analysis. Immunol Today, 21:619–623.
Ohnmacht, G.A., Wang, E., Mocellin, S., Abati, A., Filie, A., Fetsch, P., Riker, A.I., Kammula, U.S., Rosenberg, S.A., and Marincola, F.M., 2001, Short term kinetics of tumour antigen expression in response to vaccination. J. Immunol, 167:1809–1820.
Brown, P.O., and Botstein, D., 1999, Exploring the new world of the genome with DNA microarrays. Nat Genet, 21:33–37.
Wang, E., Miller, L.D., Ohnmacht, G.A., Mocellin, S., Perez-Diez, A., Petersen, D., Zhao, Y., Simon, R., Powell, J.I., Asaki, E., Alexander, H.R., Duray, P.H., Herlyn, M., Restifo, N.P., Liu, E.T., Rosenberg, S.A., and Marincola, F.M., 2002, Prospective molecular profiling of subcutaneous melanoma metastases suggests classifiers of immune responsiveness. Cancer Res, 62:3581–3586.
Panelli, M.C., Wang, E., Phan, G., Puhlmann, M., Miller, L., Ohnmacht, G.A., Klein, H.G., and Marincola, F.M., 2002, Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol, 3:RESEARCH0035.
Nagorsen, D., Marincola, F.M., and Panelli, M.C., 2004, Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays. Cytokine, 25:31–5.
van’ t Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., Schreiber, G.J., Kerkhoven, R.M., Roberts, C., Linsley, P.S., Bernards, R., and Friend, S.H., 2002, Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415:530–6.
van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., Witteveen A., Glas A., Delahaye L., van der Velde T., Bartelink H., Rodenhuis S., Rutgers E.T., Friend S.H., and Bernards R., 2002, A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009.
Nagorsen D., and Marincola F.M., Kaiser H.E., 2002, Bacteria-related spontaneous and therapeutic remission of human malignancies. In Vivo 16:551–556.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
Nagorsen, D., Marincola, F.M. (2005). Dynamic Nature of Tumour-Host Interactions Within the Tumor Microenvironment. In: Meadows, G.G. (eds) Integration/Interaction of Oncologic Growth. Cancer Growth and Progression, vol 15. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3414-8_10
Download citation
DOI: https://doi.org/10.1007/1-4020-3414-8_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3413-8
Online ISBN: 978-1-4020-3414-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)